Quotient Wealth Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.29M Sell
3,575
-7
-0.2% -$7.1K 0.09% 65
2025
Q4
$3.85M Sell
3,582
-101
-3% -$96.6K 0.1% 57
2025
Q3
$2.81M Sell
3,683
-43
-1% -$32K 0.08% 64
2025
Q2
$2.9M Buy
3,726
+374
+11% +$291K 0.09% 61
2025
Q1
$2.77M Buy
3,352
+198
+6% +$165K 0.09% 59
2024
Q4
$2.43M Buy
3,154
+145
+5% +$120K 0.08% 59
2024
Q3
$2.67M Sell
3,009
-104
-3% -$93.5K 0.09% 54
2024
Q2
$2.82M Buy
3,113
+458
+17% +$366K 0.1% 52
2024
Q1
$2.07M Sell
2,655
-78
-3% -$55.5K 0.07% 73
2023
Q4
$1.59M Buy
+2,733
New +$1.6M 0.06% 92

Other funds holding LLY

Quotient Wealth Partners's LLY Position: Q1 2026 in Review

Quotient Wealth Partners reduced its Eli Lilly (LLY) stake by 0.2% in Q1 2026, selling an estimated $7.1K and leaving 3,575 shares worth $3.29M. The position accounts for 0.09% of the portfolio, ranked #65.

Quotient Wealth Partners first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $3.85M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Quotient Wealth Partners held 3,575 shares of Eli Lilly worth $3.29M as of Q1 2026.
  • Quotient Wealth Partners sold 7 Eli Lilly shares in Q1 2026, an estimated $7.1K.
  • Eli Lilly made up 0.09% of Quotient Wealth Partners's portfolio in Q1 2026, its #65 holding.
  • Quotient Wealth Partners first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • Quotient Wealth Partners's Eli Lilly position peaked at $3.85M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Quotient Wealth Partners's 13F filing for Q1 2026, filed 16 Apr 2026.